Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004650267 | SCV005145876 | uncertain significance | not specified | 2024-05-02 | criteria provided, single submitter | clinical testing | The c.1261A>G (p.R421G) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a A to G substitution at nucleotide position 1261, causing the arginine (R) at amino acid position 421 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |